Efficacy and safety of tofacitinib in the treatment of refractory chronic spontaneous urticaria: A real-world study.
Chen A, Li R, Yang X, Huang X, Mu Z, Li S, Deng S, Huan W, Zhang M, Li J, Song Z, Chen Q
Journal of the American Academy of DermatologyIn the feed 2 Sep 2026, published online 2 Sep 2026, issue 2026 Sep 02, added to PubMed 2 Sep 2026
Topics: Urticaria
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42685910 · DOI 10.1016/j.jaad.2026.08.112